IntercontinentalExchange was upgraded to buy at TheStreet Ratings.
Juniper was upgraded at Wells Fargo to outperform from market perform. New CEO can help the company leverage higher enterprise demand in the coming quarters, Wells Fargo said.
Mattress Firm was initiated at Jefferies with a buy rating. Unit growth story with positive new store economics, Jefferies said. Twelve-month price target is $56.
Regal-Beloit was upgraded at Robert Baird to outperform from neutral. Valuation call, based on a 12-month price target of $87.
Sterling Bancorp was upgraded to buy at TheStreet Ratings.
Susser Petroleum was initiated at Jefferies with a hold rating. Valuation call, with positive foodservice story and 4%-5% store growth, Jefferies said. Twelve-month price target is $72.
Teva was upgraded at Goldman Sachs to neutral from sell. Copaxone slowdown is largely priced in and the underlying business can deliver growth, Goldman Sachs said. Twelve-month price target is $52.
Wisdomtree was downgraded at Citigroup to sell from neutral. Twelve-month price target is $11. Estimates were also cut, given lower expected organic growth, Citigroup said.
Stock Comments / EPS Changes
AbbVie price target was lowered at Jefferies. Competitive data in Hep C, pay for delay litigation re Androgel, Jefferies said. Twelve-month price target is $60.
Abbott price target was cut at Jefferies. Pricing pressure in EPD, MD pricing/volume pressure and FX exposure, Jefferies said. Twelve-month price target is now $45. Buy rating.
Adobe estimates, price target were raised at JMP Securities. Shares are now seen reaching $78. Estimates were also increased, given the company's guidance, JMP Securities said. Outperform rating.
Dow Chemical estimates, price target were boosted at Citigroup. Twelve-month price target is now $57. Estimates were also increased, given higher expected ethylene margins, Citigroup said. Buy rating.
Enterprise Products Partners 12-month price target was raised at UBS. Continued focus on diversification, stability and growth, UBS said. Twelve-month price target is $74. Buy rating.
Freescale estimates, 12-month price target were increased at Drexel Hamilton. Estimates were boosted through 2015. Rising capacity utilization should help margins, Drexel Hamilton said. Buy rating and new $30 price target.
Johnson & Johnson price target was lifted at Jefferies. Driven by regulatory catalysts and several major congresses, Jefferies said. Twelve-month price target is now $105. Buy rating.
Oracle price target, EPS estimates were increased at Jefferies. Valuation call, with modestly higher revenue forecasts, Jefferies said. Twelve-month price target is now $37. Hold rating.
ING estimates, price target were increased at Credit Suisse. Estimates were raised through 2015. Company is returning more capital to shareholders, Credit Suisse said. Neutral rating and new 12-month price target of $41.
Follow TheStreet on Twitter and become a fan on Facebook